Ember Therapeutics's total assets for Q were $2.30K, a decrease of -18.51% from the previous quarter. EMBT total liabilities were $254.80K for the fiscal quarter, a 0.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.